The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 08, 2025

Filed:

Mar. 16, 2023
Applicant:

Virginia Tech Intellectual Properties, Inc., Blacksburg, VA (US);

Inventors:

John L. Robertson, Floyd, VA (US);

Ryan Senger, North Chesterfield, VA (US);

Pang Du, Blacksburg, VA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 21/65 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61M 1/14 (2006.01); A61M 1/16 (2006.01); A61M 1/28 (2006.01); A61M 1/36 (2006.01); G01N 33/49 (2006.01); G16H 10/40 (2018.01); G16H 20/40 (2018.01);
U.S. Cl.
CPC ...
G01N 21/65 (2013.01); A61B 5/0075 (2013.01); A61B 5/14525 (2013.01); A61B 5/6866 (2013.01); A61M 1/14 (2013.01); A61M 1/1609 (2014.02); A61M 1/1619 (2014.02); A61M 1/1692 (2013.01); A61M 1/282 (2014.02); A61M 1/3609 (2014.02); G01N 33/492 (2013.01); G16H 10/40 (2018.01); G16H 20/40 (2018.01); A61M 2205/3313 (2013.01); A61M 2205/50 (2013.01); A61M 2205/52 (2013.01); G01N 21/658 (2013.01); G01N 2570/00 (2013.01);
Abstract

A system and method for monitoring the health of dialysis patients with Raman spectroscopy measurements of one or more target analytes is described. The methods include irradiating one or more fluids of interest with light to produce one or more spectrum and detecting the spectrum with a detector. The fluids of interest are preferably those related to dialysis, including hemodialysis and peritoneal dialysis. In a preferred embodiment, the fluids are irradiated with monochromatic light, and one or more Raman spectra are detected as a result of the irradiation. The fluids may be irradiated within the dialysis tubing itself, or removed from the dialysis tubing and irradiated in a separate chamber. The Raman spectra of one or more target analytes of a dialysis patient may be followed over time or compared to one or more reference spectra, thereby providing information on the health of dialysis patients.


Find Patent Forward Citations

Loading…